Inherited risk factors for deep venous thrombosis following total hip arthroplasty in Japanese patients: Matched control study

Journal of Orthopaedic Science

Volumn 12, Issue 2, 2007, Pages 118-122

  Kiyoshige, Yoshiro ^a   Kure, Shigeo ^b   Goto, Kaoru ^c   Ishii, Masaji ^a   Kanno, Junko ^b   Hiratsuka, Masahiro ^b,d  

^a Saiseikai Yamagata Hospital   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PLASMINOGEN; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; ELECTIVE SURGERY; FEMALE; GENETIC RISK; HUMAN; INHERITANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TOTAL HIP PROSTHESIS;

EID: 34248197863     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-006-1100-3     Document Type: Article

References (22)

1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516-30.
2. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
3. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984;74:2082-8.
4. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-6.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
6. Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
7. Hsu T-S, Hsu L-A, Chang C-J, Sun C-F, Ko Y-L, Kuo C-T, et al. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population: a case-control study. Thromb Res 2001;102:387-95.
8. Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Prevalence of the C677T methylenetetra-hydrofolate reductase mutation in Thai patients with deep vein thrombosis. Acta Haematol 2000;103:191-6.
9. Shen M-C, Lin J-S, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 2000;99:447-52.
10. Liu HW, Kwong YL, Bourke C, Lam CK, Lie AKW, Wei D, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost 1994;71:416-9.
11. Sakata T, Okamoto A, Mannami T, Matsuo H, Miyata T. Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Thromb Haemost 2004;2:528-30.
12. Yamada N, Nakamura M, Ishikura K, Ota M, Yazu T, Hiraoka N, et al. Epidemiological characteristics of acute pulmonary thromboembolism in Japan. Int Angiol 2003;22:50-4.
13. Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis 2001;12:95-9.
14. Fujimura H, Kawasaki T, Sakata T, Ariyoshi H, Kato H, Monden M, et al. Common C677T polymorphism in the methylene tetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia. Thromb Res 2000;98:1-8.
15. Mont MA, Jones LC, Rajadhyaksha AD, Shuler MS, Hungerford DS, Sieve-Smith L, et al. Risk factors for pulmonary emboli after total hip or knee arthroplasty. Clin Orthop 2004;422:154-63.
16. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am 2002;84:2161-7.
17. Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 2002;87:580-5.
18. Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop 2000;375:168-74.
19. HoagluQnd FT. Correspondence: incidence and natural history of deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br 2004;86:621.
20. Lowe GDO, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AGG, et al. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables; the ECAT DVT study: European Concerted Action on Thrombosis. Thromb Haemost 1999;81:879-86.
21. Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1995;74:1381-2.
22. Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis 1998;9:451-2.